 complications cardiopulmonary bypass Bleeding CPB difficult treatment difficult complexity problem hemostatic process technical variations operative procedures many uncontrolled variables CPB effects anesthetic pharmacologic agents nature solution hemodilution hypothermia type oxygenator use transfused blood products multiple predictable complex changes hemostatic mechanism CPB temporary loss platelet function common relevant transient platelet dysfunction patients undergoing CPB excessive bleeding small percentage patients possible patients hemorrhagic complications prolonged pump times risk factor past decade extensive investigation management CPB increased awareness transfusion-transmitted viral diseases excessive use homologous blood products Several approaches autotransfusion blood autologus blood donation perioperative homologous blood transfusion Pharmacologic agents desmopressin aprotinin topical fibrin glues hemostasis CPB protease inhibitor aprotinin promising reduction CPB Aprotinin new insights mechanism CPB-induced platelet dysfunction Desmopressin treatment bleeding CPB management CPB